Research behind COVID vaccines reaps close to $1 billion in royalties for Penn
PHILADELPHIA — The University of Pennsylvania has reaped extraordinary financial gain from COVID-19 vaccines — approaching $1 billion since the beginning of last year — thanks to patents on a process Penn researchers developed more than 15 years ago.
The Philadelphia Inquirer ·